Subscribe To
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...
October 31, 2023, 9:05 am
Aledade celebrates the election of dr. jen brull as president of the american academy of family physicians
Aledade’s Vice President of Clinical Engagement becomes the president-elect of the largest medical society...
October 27, 2023, 6:41 pm
Cybersecurity at the crossroads - can it keep up with threats?
The need of cybersecurity has become increasingly clear in a society dominated by digital communication...
October 27, 2023, 8:11 am
Seelos therapeutics to present a poster on sls-005 in alzheimer's disease at neuroscience 2023
-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzheimer's disease, Huntington's disease, Amyotroph...
October 27, 2023, 8:11 am
Apollomics announces report of activity of vebreltinib in glioblastoma multiforme (gbm) with ptprz-met fusion
FOSTER CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), today announced a report by the Veneto Ins...
October 26, 2023, 12:50 pm
Opko health to present new clinical data on rayaldee (er calcifediol) at kidney week 2023
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calc...
October 25, 2023, 8:25 pm
Opko health to present new clinical data on rayaldee (er calcifediol) at kidney week 2023
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calci...
October 25, 2023, 4:25 pm
Carisma to present first results from in vivo car-m collaboration with moderna at sitc 2023
-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data ...
October 25, 2023, 9:11 am
Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discove...
October 25, 2023, 9:05 am
Next avenue: women live longer, but save less: here’s what to do about it
Women save less than men, and the poverty rate for older women is rising. Here are the many reasons why, what they can do to catch up and how ...
October 25, 2023, 9:01 am
From bill gates to the pope, talk of carbon capture and its efficacy is dividing society
The sector's potential was a hot topic at the recent ADIPEC oil and gas conference....
October 25, 2023, 12:57 am
Aclarion announces nociscan® cost-effectiveness poster presented at 45th annual smdm meeting
Nociscan cost-effectiveness abstract poster highlights dominance over provocative discography. The 45th Annual ...
October 24, 2023, 12:45 pm
Revolut adds european stocks to platform
Rolandas Juteika, Head of Wealth and Trading (EEA), noted that the FinTech company works continuously to make investing and trading accessible to all ...
October 24, 2023, 10:36 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am